RESUMO
This report describes the outcomes of a modified laparoscopic-assisted cystotomy for urolith removal in dogs and cats. Modifications of the original techniques included a temporary cystopexy to the abdominal wall, utilization of a laparoscope instead of cystoscope, and retrograde flow of saline in the bladder with pressurized saline. The medical records of 23 client-owned animals for which laparoscopic-assisted cystotomy was used for urolith extraction were reviewed. Twenty-six procedures were performed in 23 animals. There were intraoperative complications in 19.2% of cases leading to open conversion in 11.5%. Rate of complications directly related to the procedure was 11.5%. Four cases had documented urolith recurrence with a mean time to recurrence of 335 days.
Cystotomie assistée par laparoscopie pour l'enlèvement des urolithes chez les chiens et les chats 23 cas. Ce rapport décrit les résultats d'une cystotomie assistée par laparoscopie pour l'enlèvement des urolithes chez les chiens et les chats. Les modifications des techniques originales ont inclus une cystopexie temporaire à la paroi abdominale et un flux rétrograde de la solution saline dans la vessie avec une solution saline sous pression. Les dossiers médicaux de 23 animaux appartenant à des propriétaires pour lesquels la cystotomie par laparoscopie avait été utilisée pour l'extraction des urolithes ont été examinés. Vingt-six interventions ont été réalisées chez 23 animaux. Il y a eu des complications peropératoires dans 19,2 % des cas causant une conversion ouverte à 11,5 %. Le taux des complications directement reliées à l'intervention était de 11,5 %. Pour quatre cas, il y a eu une récurrence documentée des urolithes avec une durée moyenne de 335 jours.(Traduit par Isabelle Vallières).
Assuntos
Doenças do Gato/cirurgia , Cistotomia/veterinária , Doenças do Cão/cirurgia , Cálculos da Bexiga Urinária/veterinária , Urolitíase/veterinária , Animais , Oxalato de Cálcio , Gatos , Cistotomia/métodos , Cães , Feminino , Masculino , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/veterinária , Recidiva , Resultado do Tratamento , Cálculos da Bexiga Urinária/química , Cálculos da Bexiga Urinária/cirurgia , Urolitíase/cirurgiaRESUMO
Databases (2001-2008) for cases in which recombinant bone morphogenetic protein (rhBMP) was used to aid in management of orthopedic disease were reviewed and cases were categorized as non-unions, delayed unions, and cases expected to heal with difficulty. If follow-up in the medical record was < 6 mo for live animals, owners were surveyed by telephone. Thirteen cases (11 dogs, 2 cats) were identified; OP-1 (rhBMP-7) was used in 3 cases and INFUSE (rhBMP-2) in 10. Mean time from injury to rhBMP use for non- and delayed union cases was 156 d; mean time from rhBMP use to radiographic healing was 101 d. No systemic side effects were reported. All patients achieved clinical and radiographic bone union following rhBMP administration. Recombinant human BMP was used in 13 veterinary patients to successfully achieve bone union without serious deleterious effects in a variety of clinical applications.
